VAL401
- Generic Name
- VAL401
A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- ValiSeek Limited
- Target Recruit Count
- 8
- Registration Number
- NCT02875340
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath